Literature DB >> 1742728

Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard.

P M O'Connor1, K Wassermann, M Sarang, I Magrath, V A Bohr, K W Kohn.   

Abstract

We surveyed 11 Burkitt's lymphoma cell lines for chemosensitivity to nitrogen mustard (HN2) in order to determine whether any simple correlates to cytotoxic response might be revealed. The lines tested varied over a 5-fold range in concentration of HN2 required to inhibit tumor cell growth by 50%. Drug sensitivity correlated neither with continental origin of tumor, growth fraction, presence of Epstein-Barr virus, nor with the precise locations of (8;14) translocation breakpoints. Furthermore, contrary to experience with other cell lines, no simple correlation was found between the HN2 sensitivity of the four most divergent lines (low sensitivity, CA46 and MC116 cells; high sensitivity, Namalwa and JLP119 cells) and exposure to DNA cross-links (area under the DNA cross-linking-versus-time curve). In addition, we found similar extents of gene-specific HN2-induced damage in the native and translocated c-myc alleles of CA46 and JLP119 cells. At equimolar HN2 treatment, CA46 cells exhibited a profound arrest in G2M phase, while JLP119 cells exhibited prolonged S-phase delay. This suggested that despite similar DNA cross-link exposure, JLP119 cells were less able to complete DNA replication while repair was in progress. As cell cycle distribution returned to near normal, JLP119 cells exhibited DNA degradation characterized by oligonucleosome-sized DNA fragments prior to cell membrane disintegration. Our findings indicate that HN2-sensitive Burkitt's lymphoma cells may be more susceptible to delay in S phase for a given frequency of DNA cross-links and that prolongation of S phase correlated with apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742728

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 2.  Metabolism and pharmacokinetics of oxazaphosphorines.

Authors:  A V Boddy; S M Yule
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

3.  DNA polymerase II (polB) is involved in a new DNA repair pathway for DNA interstrand cross-links in Escherichia coli.

Authors:  M Berardini; P L Foster; E L Loechler
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

4.  Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.

Authors:  Mark Roschewski; Kieron Dunleavy; Jeremy S Abramson; Bayard L Powell; Brian K Link; Prapti Patel; Philip J Bierman; Deepa Jagadeesh; Ronald T Mitsuyasu; David Peace; Peter R Watson; Wahid T Hanna; Christopher Melani; Andrea N Lucas; Seth M Steinberg; Stefania Pittaluga; Elaine S Jaffe; Jonathan W Friedberg; Brad S Kahl; Richard F Little; Nancy L Bartlett; Michelle A Fanale; Ariela Noy; Wyndham H Wilson
Journal:  J Clin Oncol       Date:  2020-05-26       Impact factor: 44.544

5.  Apoptosis induced by etoposide in small-cell lung cancer cell lines.

Authors:  S Okamoto-Kubo; K Nishio; Y Heike; M Yoshida; T Ohmori; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes.

Authors:  Flávio Dionísio; Ana Margarida Araújo; Margarida Duarte-Araújo; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2022-01-28       Impact factor: 5.153

7.  Development of a cancer DNA phenotype prior to tumor formation.

Authors:  Donald C Malins; Katie M Anderson; Naomi K Gilman; Virginia M Green; Edward A Barker; Karl Erik Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.

Authors:  S Ray; V Ponnathpur; Y Huang; C Tang; M E Mahoney; A M Ibrado; G Bullock; K Bhalla
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.

Authors:  Kristoph Jahnke; Leslie L Muldoon; Csanad G Varallyay; Seth J Lewin; Robert D Brown; Dale F Kraemer; Carole Soussain; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2009-01-21       Impact factor: 12.300

10.  Low-intensity therapy in adults with Burkitt's lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Margaret Shovlin; Seth M Steinberg; Diane Cole; Cliona Grant; Brigitte Widemann; Louis M Staudt; Elaine S Jaffe; Richard F Little; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.